156 related articles for article (PubMed ID: 30656221)
1. A propensity analysis comparing definitive chemo-radiotherapy for muscle-invasive squamous cell carcinoma of the bladder vs. urothelial carcinoma of the bladder using the National Cancer Database.
Fischer-Valuck BW; Michalski JM; Contreras JA; Brenneman R; Christodouleas JP; Abraham CD; Kim EH; Arora VK; Bullock AD; Carmona R; Figenshau RS; Grubb R; Knoche EM; Pachynski RK; Picus J; Roth BJ; Sargos P; Andriole GL; Gay HA; Baumann BC
Clin Transl Radiat Oncol; 2019 Feb; 15():38-41. PubMed ID: 30656221
[TBL] [Abstract][Full Text] [Related]
2. Propensity matched comparative analysis of survival following chemoradiation or radical cystectomy for muscle-invasive bladder cancer.
Ritch CR; Balise R; Prakash NS; Alonzo D; Almengo K; Alameddine M; Venkatramani V; Punnen S; Parekh DJ; Gonzalgo ML
BJU Int; 2018 May; 121(5):745-751. PubMed ID: 29281848
[TBL] [Abstract][Full Text] [Related]
3. Concurrent chemotherapy is associated with improved survival in elderly patients with bladder cancer undergoing radiotherapy.
Korpics MC; Block AM; Martin B; Hentz C; Gaynor ER; Henry E; Harkenrider MM; Solanki AA
Cancer; 2017 Sep; 123(18):3524-3531. PubMed ID: 28581675
[TBL] [Abstract][Full Text] [Related]
4. Does Chemo-Radiotherapy Improve Survival Outcomes vs. Radiotherapy Alone for High-Grade cT1 Urothelial Carcinoma of the Bladder?
Andruska N; Waters MR; Fischer-Valuck BW; Smith ZL; Kim EH; Reimers M; Brenneman R; Gay HA; Patel SA; Michalski JM; Delacroix SE; Efstathiou JA; Baumann BC
Clin Genitourin Cancer; 2023 Dec; 21(6):653-659.e1. PubMed ID: 37704483
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic and Survival After Cystectomy Outcomes in Squamous Cell Carcinoma of the Bladder.
Agrawal P; Rostom M; Alam R; Florissi I; Biles M; Rodriguez K; Hahn NM; Johnson BA; Matoso A; Smith A; Bivalacqua TJ; Kates M; Hoffman-Censits J; Patel SH
Clin Genitourin Cancer; 2023 Dec; 21(6):631-638.e1. PubMed ID: 37336703
[TBL] [Abstract][Full Text] [Related]
6. Bladder preserving chemoradiotherapy compared to surgery for variants of urothelial carcinoma and other tumors types involving the bladder: An analysis of the National Cancer Database.
Janopaul-Naylor JR; Zhong J; Liu Y; Zhang C; Osunkoya AO; Joshi SS; Bilen MA; Carthon B; Kucuk O; Hartsell LM; Shelton J; Jani AB
Clin Transl Radiat Oncol; 2021 Jan; 26():30-34. PubMed ID: 33294644
[TBL] [Abstract][Full Text] [Related]
7. Contemporary use trends and survival outcomes in patients undergoing radical cystectomy or bladder-preservation therapy for muscle-invasive bladder cancer.
Cahn DB; Handorf EA; Ghiraldi EM; Ristau BT; Geynisman DM; Churilla TM; Horwitz EM; Sobczak ML; Chen DYT; Viterbo R; Greenberg RE; Kutikov A; Uzzo RG; Smaldone MC
Cancer; 2017 Nov; 123(22):4337-4345. PubMed ID: 28743162
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Outcomes in Patients With Muscle-invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder Preservation.
Zhong J; Switchenko J; Jegadeesh NK; Cassidy RJ; Gillespie TW; Master V; Nieh P; Alemozaffar M; Kucuk O; Carthon B; Filson CP; Bilen MA; Jani AB
Am J Clin Oncol; 2019 Jan; 42(1):36-41. PubMed ID: 29912804
[TBL] [Abstract][Full Text] [Related]
9. National Cancer Database Comparison of Radical Cystectomy vs Chemoradiotherapy for Muscle-Invasive Bladder Cancer: Implications of Using Clinical vs Pathologic Staging.
Lin HY; Ye H; Kernen KM; Hafron JM; Krauss DJ
Cancer Med; 2018 Nov; 7(11):5370-5381. PubMed ID: 30306728
[TBL] [Abstract][Full Text] [Related]
10. The impact of squamous histology on survival in patients with muscle-invasive bladder cancer.
Matulay JT; Woldu SL; Lim A; Narayan VM; Li G; Kamat AM; Anderson CB
Urol Oncol; 2019 Jun; 37(6):353.e17-353.e24. PubMed ID: 30704959
[TBL] [Abstract][Full Text] [Related]
11. Improved survival with definitive chemoradiation compared to definitive radiation alone in squamous cell carcinoma of the vulva: A review of the National Cancer Database.
Rao YJ; Chin RI; Hui C; Mutch DG; Powell MA; Schwarz JK; Grigsby PW; Markovina S
Gynecol Oncol; 2017 Sep; 146(3):572-579. PubMed ID: 28662775
[TBL] [Abstract][Full Text] [Related]
12. Upfront surgery versus definitive chemoradiotherapy in patients with human Papillomavirus-associated oropharyngeal squamous cell cancer.
Kelly JR; Park HS; An Y; Yarbrough WG; Contessa JN; Decker R; Mehra S; Judson BL; Burtness B; Husain Z
Oral Oncol; 2018 Apr; 79():64-70. PubMed ID: 29598952
[TBL] [Abstract][Full Text] [Related]
13. Bladder only versus bladder plus pelvic lymph node chemoradiation for muscle-invasive bladder cancer.
Patel SA; Liu Y; Solanki AA; Baumann BC; Efstathiou JA; Jani AB; Chang AJ; Fischer-Valuck B; Royce TJ
Urol Oncol; 2023 Jul; 41(7):325.e15-325.e23. PubMed ID: 36725382
[TBL] [Abstract][Full Text] [Related]
14. Surgery Versus Chemotherapy and Radiotherapy For Early and Locally Advanced Small Cell Lung Cancer: A Propensity-Matched Analysis of Survival.
Wakeam E; Acuna SA; Leighl NB; Giuliani ME; Finlayson SRG; Varghese TK; Darling GE
Lung Cancer; 2017 Jul; 109():78-88. PubMed ID: 28577955
[TBL] [Abstract][Full Text] [Related]
15. Survival benefits and predictors of use of chemoradiation compared with radiation alone for early stage (T1-T2N0) anal squamous cell carcinoma.
Youssef I; Osborn V; Lee A; Katsoulakis E; Kavi A; Choi K; Safdieh J; Schreiber D
J Gastrointest Oncol; 2019 Aug; 10(4):616-622. PubMed ID: 31392041
[TBL] [Abstract][Full Text] [Related]
16. Treatment Patterns and Survival Outcomes for Patients with Small Cell Carcinoma of the Bladder.
Fischer-Valuck BW; Rao YJ; Henke LE; Rudra S; Hui C; Baumann BC; Gay HA; Michalski JM
Eur Urol Focus; 2018 Dec; 4(6):900-906. PubMed ID: 28919521
[TBL] [Abstract][Full Text] [Related]
17. Pathological Downstaging and Survival Outcomes Associated with Neoadjuvant Chemotherapy for Variant Histology Muscle Invasive Bladder Cancer.
Chakiryan NH; Jiang DD; Gillis KA; Green E; Hajiran A; Hugar L; Zemp L; Zhang J; Jain R; Chahoud J; Poch M; Manley BJ; Li R; Sexton W; Gilbert SM
J Urol; 2021 Oct; 206(4):924-932. PubMed ID: 34032503
[TBL] [Abstract][Full Text] [Related]
18. The Impact of Plasmacytoid Variant Histology on the Survival of Patients with Urothelial Carcinoma of Bladder after Radical Cystectomy.
Li Q; Assel M; Benfante NE; Pietzak EJ; Herr HW; Donat M; Cha EK; Donahue TF; Bochner BH; Dalbagni G
Eur Urol Focus; 2019 Jan; 5(1):104-108. PubMed ID: 28753857
[TBL] [Abstract][Full Text] [Related]
19. Sociodemographic and survival disparities for histologic variants of bladder cancer.
Jue JS; Koru-Sengul T; Moore KJ; Miao F; Alameddine M; Nahar B; Punnen S; Parekh DJ; Ritch CR; Gonzalgo ML
Can J Urol; 2018 Feb; 25(1):9179-9185. PubMed ID: 29524972
[TBL] [Abstract][Full Text] [Related]
20. Comparison of structural genetics of non-schistosoma-associated squamous cell carcinoma of the urinary bladder.
Molitor M; Junker K; Eltze E; Toma M; Denzinger S; Siegert S; Knuechel R; Gaisa NT
Int J Clin Exp Pathol; 2015; 8(7):8143-58. PubMed ID: 26339383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
